CERo Therapeutics Holdings Inc (CERO) concluded trading on Thursday at a closing price of $1.11, with 71.48 million shares of worth about $79.34 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -87.23% during that period and on April 24, 2025 the price saw a gain of about 38.85%. Currently the company’s 3.66M shares are available for trading.
Stock saw a price change of 85.93% in past 5 days and over the past one month there was a price change of 25.28%. Year-to-date (YTD), CERO shares are showing a performance of -81.50% which decreased to -99.22% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.53 but also hit the highest price of $171.00 during that period. The average intraday trading volume for CERo Therapeutics Holdings Inc shares is 721.30K. The stock is currently trading 52.00% above its 20-day simple moving average (SMA20), while that difference is down -1.84% for SMA50 and it goes to -87.14% lower than SMA200.
The stock has a current market capitalization of $5.97M and its 3Y-monthly beta is at 0.62. It has posted earnings per share of -$126.72 in the same period. It has Quick Ratio of 0.49. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CERO, volatility over the week remained 22.92% while standing at 17.04% over the month.
Analysts are in expectations that CERo Therapeutics Holdings Inc (CERO) stock would likely to be making an EPS of -5.96 in the current quarter, while forecast for next quarter EPS is -0.53 and it is -0.86 for next year. For the current quarter EPS, analysts have given the company a lowest target -5.96 which is -5.96 at the higher side of the target for the same.
